Total planned funding: $136,307,933
Allocations
Countries/Regions
India | $136,307,933 |
Organizational Types
NGO | $48,598,284 |
Unknown | $33,755,489 |
Own Agency | $24,858,171 |
University | $16,640,217 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
FBO | $2,000,000 |
Multi-lateral Agency | $2,000,000 |
Host Country Government Agency | $1,609,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $61,164,862 |
Prevention | $30,670,704 |
Management and Operations | $18,454,719 |
Care | $16,807,500 |
Treatment | $4,669,170 |
Testing | $4,540,978 |
Budget Codes
OHSS: Health Systems Strengthening | $36,560,040 |
HVMS: Management and Operations | $18,454,719 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,402,731 |
HVSI: Strategic Information | $18,240,859 |
HBHC: Care: Adult Care and Support | $10,132,830 |
HLAB: Laboratory Infrastructure | $6,363,963 |
HVCT: Testing: HIV Testing and Counseling | $4,540,978 |
HTXS: Treatment: Adult Treatment | $4,077,629 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,529,475 |
HKID: Care: Orphans and Vulnerable Children | $3,419,204 |
HMBL: Biomedical Prevention: Blood Safety | $3,343,862 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,013,708 |
HVTB: Care: TB/HIV | $2,862,720 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,380,928 |
PDTX: Treatment: Pediatric Treatment | $568,064 |
PDCS: Care: Pediatric Care and Support | $392,746 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$32,708,000
Countries/Regions
USG Aggregated Agencies:
$12,911,741
Countries/Regions
Voluntary Health Services:
$11,040,000
Countries/Regions
FHI 360:
$10,863,654
Countries/Regions